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Abstract
Glial cells are increasingly recognized as active players that profoundly influence neuronal
synaptic transmission by specialized signalling pathways. In particular, astrocytes have recently
been shown to release small molecules such as the amino acids L-glutamate and D-serine as
“gliotransmitters”, which directly control the efficacy of adjacent synapses. However, it is still
controversial whether gliotransmitters are released from a cytosolic pool or by Ca2+-dependent
exocytosis from secretory vesicles, i.e., by a mechanism similar to the release of synaptic vesicles
in synapses. Here we report that rat cortical astrocytes contain storage vesicles that display
morphological and biochemical features similar to neuronal synaptic vesicles. These vesicles share
some, but not all, membrane proteins with synaptic vesicles including the SNARE synaptobrevin 2
and contain both L-glutamate and D-serine. Furthermore, they show uptake of L-glutamate and D-
serine that is driven by a proton electrochemical gradient. D-Serine uptake is associated with
vesicle acidification and is dependent on chloride. While L-serine is not transported, serine
racemase, the synthesizing enzyme for D-serine, is anchored to the membrane of the vesicles
allowing local generation of D-serine. Finally, we reveal a previously unexpected mutual vesicular
synergy between D-serine and L-glutamate filling in glia vesicles. We conclude that astrocytes
contain vesicles capable of storing and releasing D-serine, L-glutamate, and most likely other
neuromodulators in an activity-dependent manner.
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Introduction
Glial cells and particularly astrocytes control synaptic strength and hence participate in
normal and pathological brain function (Halassa and Haydon, 2010) through the regulated
release of neuromodulators called gliotransmitters (Volterra and Meldolesi, 2005). The
mechanisms for gliotransmitter release remain ill-defined. Two main routes have been
proposed: 1) non-exocytotic release from cytosolic pools by membrane proteins, 2) Ca2+-
regulated exocytosis which requires the storage of gliotransmitters in secretory organelles
(Volterra and Meldolesi, 2005; Halassa and Haydon, 2010; Hamilton and Attwell, 2010).
Among gliotransmitters, D-serine is recognized as an important signalling molecule that
gates the activity of the synaptic N-methyl D-aspartate (NMDA) receptors in many brain
areas (Mothet et al., 2000; Panatier et al., 2006; Henneberger et al., 2010; Fossat et al.,
2012). Besides its physiological functions, D-serine promotes excitotoxicity when released in
excess (Martineau et al., 2006). Hence, deletion of the biosynthetic enzyme, serine
racemase, confers neuronal protection against ischemic and related cerebral injuries (Inoue
et al., 2008; Mustafa et al., 2010).
Several lines of physiological evidence have suggested that glia may exocytose D-serine.
Indeed, release is triggered by calcium rises and is inhibited by both tetanus neurotoxin and
by blockers of V-ATPase (Mothet et al., 2005; Martineau et al., 2008). Also, D-serine
immunoreactivity colocalizes with markers of the regulated secretory pathway such as the
SNARE (soluble Nethylmaleimide-sensitive factor attachment protein (SNAP) receptor)
synaptobrevin 2 (Sb2) (Martineau et al., 2008). Furthermore, tetanus neurotoxin injection or
cytosolic calcium clamping suppressed long-term potentiation in the Schaffer collateral -
CA1 pyramidal cell synapses (Henneberger et al., 2010); these inhibitory effects were fully
reversed by adding D-serine. Interestingly, L-glutamate, another important gliotransmitter,
undergoes Ca2+- and SNARE-dependent release to modulate synaptic functions (Araque et
al., 2000; Bezzi et al., 2004; Montana et al., 2004; Jourdain et al., 2007).
Nevertheless, the evidence for exocytotic release of D-serine and L-glutamate is mostly
indirect and the exocytotic release hypothesis is confounded by the observation that glial
cells can also release these gliotransmitters through non-exocytotic mechanisms (for reviews
see Volterra and Meldolesi, 2005; Hamilton and Attwell, 2010). Thus, it cannot be excluded
that tetanus neurotoxin or calcium clamping inhibits the regulated exocytotic insertion of
transporters or ion channels into the plasma membrane, which are needed for (stimulated)
release of gliotransmitters.
Another issue with the general acceptance for Ca2+-regulated exocytosis of gliotransmitters
is that the nature of the putative storage organelles is unknown. Furthermore, scant
information exists about the mechanisms by which gliotransmitters are sequestered and
stored. Therefore, obtaining such evidence is of fundamental importance for proving the
concept of D-serine and L-glutamate exocytosis. Here we have carried out a detailed analysis
of the contents and uptake features of Sb2-bearing secretory organelles isolated from
astrocytes using multiple experimental approaches. We show that Sb2-positive glial
secretory vesicles have morphological and biochemical features similar to synaptic vesicles
(SVs) and store both L-glutamate and D-serine. Uptake of these gliotransmitters is energized
by a proton electrochemical gradient generated by a V-ATPase and critically depends on
chloride ions. Finally, we show that synthesis and vesicular uptake of D-serine are coupled
and that a mutual synergy exists between D-serine and L-glutamate uptakes in astroglial
vesicles.
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Materials and Methods
Antibodies
Monoclonal antibody clones 69.1 against rat synaptobrevin 2 (Sb2) was previously
characterized (Edelmann et al., 1995). The antibodies against the following proteins were
used: cathepsin D (Santa Cruz biotechnology), cellubrevin (Covalab), D-serine (GemacBio),
EEA1 (clone 14) and GM130 (clone 35) (Transduction Laboratories), Na+/K+-ATPase and
SV2 (Developmental Studies Hybridoma Bank), PDI (clone RL90, Abcam), PMP70 (clone
70-18, Sigma), serine racemase (Santa Cruz Biotechnology and clone 29, BD Biosciences),
synaptophysin (clone 7.2, Synaptic System), synaptotagmin 1 (clone 604.1, Synaptic
System), TfR (clone H68.4, Invitrogen), vGlut1 and vGlut2 (Millipore), glutamine synthase
(clone SH-B1, Sigma), β3-tubulin (clone TU-20, Chemicon) and glial fibrillary acidic
protein (GFAP, DAKO). Rabbit polyclonal antibodies against Serine Racemase, SNAP23
and V-ATPase were kind gifts of Herman Wolosker (Technion-Israel Institute of
Technology, Haifa, Israel), Thierry Galli (INSERM, Paris, France) and Nicolas Morel
(CNRS, Gifsur-Yvette, France), respectively. Mouse monoclonal IgG1 was from Serotec
(France). Secondary antibodies conjugated to horseradish peroxidase and Alexa Fluor 488 or
546 were obtained from P.A.R.I.S. and Invitrogen, respectively. Biotinylated donkey anti-
rabbit antibody was from Jackson Immunoresearch and the goat anti-rabbit IgG coupled to
1.4 nm gold particles was from Nanoprobes.
Cell cultures
Cultured cortical astroglia cells were prepared from 0- to 4-day-old postnatal Wistar rats of
either sex as previously described (Martineau et al., 2008). Cells were plated onto 150 cm²
flasks, kept at 37 °C in a 5% CO2 incubator for 14–20 days. Astroglia culture purity (>95%)
was assessed by immunostaining against the astrocytic marker GFAP.
Organelle immunoisolation
All steps were carried out at 4–6 °C for western blot and transport analysis or at 0 °C for
amino acid content analysis. For the immunoisolation of GVs, cultured astroglial cells were
washed, harvested by scraping and resuspended in homogenization buffer (4 mM HEPES-
KOH pH 7.4, 100 mM K2-tartrate, 2 mM MgCl2, protease inhibitor cocktail (Complete
EDTA-free, Roche)). Cells were homogenized using a cell cracker (clearance 10 µm,
European Molecular Biology Laboratory, Heidelberg, Germany) and the lysate was
centrifuged for 10 min at 400 g. Low speed supernatants (LSS) (containing ～1 mg/ml
protein) were incubated with monoclonal antibodies against Sb2 for 2 h under rotation and
with magnetic beads coupled to protein G (Ademtech) for one additional hour. The beads
were further washed 3 times with homogenization buffer. Unbound membranes in the
supernatant and LSS were pelleted by centrifugation at 175,000 g for 2 h in an 80Ti rotor.
All membrane or bead pellets were resuspended in SDS-PAGE sample buffer before being
processed for gel electrophoresis and immunoblotting with standard methods, or in
appropriate buffer for further analysis. Isolations with murine IgG or at 21 °C were used as a
control.
Immunoisolation of synaptic vesicles was performed following the same protocol, with the
following modifications. The rat cerebral cortex of a male Wistar rat (2 months) was
homogenized with a glass/Teflon homogenizer (10 strokes at 2,500 rpm) in homogenization
buffer immediately after decapitation. The homogenate was centrifuged for 25 min at 35.000
g. The resulting supernatant (containing ～3 mg/ml protein) was incubated 1 h with anti-Sb2
and 1 h with magnetic beads.
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Electron microscopy on isolated vesicles
Immunobeads with bound organelles were fixed in 3% glutaraldehyde in 0.1 M sodium
cacodylate (pH 7.4) for 1 h at room temperature. After a rinse in 0.1 M sodium phosphate
(pH 7.4), the beads were embedded in 1% agarose in the same buffer. Agarose blocks were
then postfixed for 1 h with OsO4 (1% in phosphate buffer), dehydrated and embedded in
Epon. During dehydration, they were stained en bloc with uranyl acetate in 50% ethanol.
Thin sections (～ 60 nm) were counter-stained with lead citrate and examined in a Philips
301 electron microscope.
Electron microscopy on brain slices
One month old Sprague-Dawley male rats were anesthetized (pentobarbital; 6 mg/100 mg
body weight) and perfused intracardially with a mix of glutaraldehyde (2.5% or 0.5%) and
paraformaldehyde (2% or 4%) in 0.1 M phosphate buffer (PB). For pre-embedding
immunoperoxidase analyses, coronal brain vibratome sections (60 εm) were pre-treated with
a cryoprotectant solution (DMSO 20%, 2% glycerin in PB) then freeze-thawed by freezing
in isopentane and thawing in PB. Sections were pre-treated with 1% NaBH4, pre-incubated
in 15% donkey serum (DS) in PBS, incubated with anti-D-serine polyclonal antibody
(1:2000), and finally incubated in biotinylated donkey anti-rabbit antibody (1:500) in PBS.
The sections were treated with an avidin-biotinylated peroxidase mixture (ABC kit, Vector)
and peroxidase enzyme activity was then revealed using a 0.05% 3,3’-diaminobenzidine
tetrahydrochloride solution added with 0.01% H2O2. Sections for pre-embedding
immunogold were incubated along with those used for immunoperoxidase up to the second
antibody stage, then incubated in goat anti-rabbit IgG coupled to 1.4 nm gold particles
(1:100) and postfixed in 1% glutaraldehyde for 10 minutes followed by silver enhancement
of the gold particles with an HQ Silver kit (Nanoprobes). The specificity of the D-serine
staining was assessed by incubating some sections with a “saturated” anti-D-serine
polyclonal antibody (previously preabsorbed with 500 µM of liquid-phase D-serine
glutaraldehyde conjugate) (Puyal et al., 2006) or without primary antibody. Under these
conditions, no immunoreactivity was detected. Sections were then postfixed in 1% OsO4,
dehydrated in graded ethanol series and flat-embedded in epoxy resin (Durcupan ACM,
Fluka, Sigma-Aldrich) on glass slides. Ultrathin sections were done (70–90 nm), mounted
on formvar-coated single slot grids, and stained with uranyl acetate followed by alkaline
lead citrate. Ultrastructural analyses were performed in a Philips CM100 transmission
electron microscope.
Acidification assay
Immunoisolated vesicles were eluted in 100 mM citrate pH 2.5 for 45 min and resuspended
in acidification assay buffer 2x to get a final buffer composition of 10 mM HEPES-KOH pH
7.4, 4 mM KCl, 4 mM MgSO4, and 0.32 M sucrose. The acidification assay was performed
by measuring the fluorescence quenching of acridine orange (AO, Molecular Probes)
(Maycox et al., 1988). The reaction was started by adding 10 mM MgATP in a stirred
microcuvette containing 50 µl of vesicles and 20 µM AO, equilibrated at 32 °C. The reaction
was stopped after 15–20 min by adding 50 mM (NH4)2SO4 to dissipate the proton gradient
across the vesicular membrane and release acridine orange from the vesicular lumen.
Changes of fluorescence were analyzed using a Photon Technology International
spectrofluorimeter (excitation: 490 nm, emission: 530 nm). The acidification kinetics were
analyzed using Felix32 software (Photon Technology International) for acquisition of AO
fluorescence and Prism4 (GraphPad) for kinetics and statistical analysis. Traces were
normalized to the fluorescence at t = 0 and corrected for baseline shifts induced by volume
changes associated with the additions.
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Uptake of radiolabelled amino acids
Amino acids uptake inside immunoisolated vesicles was analyzed by a filtration assay with
radiolabelled amino acids as described previously (Burger et al., 1991). 100 µl aliquots of
Sb2-immunoisolated beads resuspended in assay buffer (0.32 M sucrose, 4 mM KCl, 4 mM
MgSO4 and 10 mM HEPES-KOH, pH 7.4) were incubated with 400 µM D-serine or 40 µM
L-glutamate containing 4 µCi D-[3H]serine or 2 µCi L-[3H]glutamate (PerkinElmer). Uptake
activities were assayed by rapid filtration on glass fibre filters (GF/C) using a cell harvester
system (Connectorate AG) and by scintillation counting.
Determination of amino acid vesicular content
Immunoisolation was performed at 0 °C to prevent vesicular content leakage (Burger et al.,
1991). Starting material and immunoisolates were treated with 5% (w/v) trichloroacetic acid
to extract free amino acids as described (Hashimoto et al., 1992). Amino acids were
determined by a laboratory-assembled capillary electrophoresis with laser induced
fluorescence (CE-LIF) system (Scanlan et al., 2011) using pre-column derivatization with 10
mM naphthalene-2,3-dicarboxaldehyde (NDA) and 20 mM KCN for 20 min in the dark.
Chiral separation and quantitation were achieved by employing a separation buffer
consisting of 10 mM γ-cyclodextrin, 30 mM sodium dodecyl sulfate (SDS) and 75 mM
borate buffer at pH 10.5. In addition, both a CE-LIF separation with non-chiral separation
conditions (50 mM borate buffer at pH 8.42) as well as capillary electrophoresis-mass
spectrometry (CE-MS) were used to verify analyte identifications and quantitation. The
laboratory-assembled CE-MS instrument and separation conditions were as described
previously (Lapainis, 2009; Nemes et al., 2011). Amino acid contents were corrected for
nonspecific adsorption on beads determined by isolating vesicles at 21 °C, and normalized
to Sb2 quantified by immunoblotting.
Immunostainings
Astrocytes cultured on glass coverslips were immunostained with pairs of antibodies as
described previously (Martineau et al., 2008). Immunostainings of cerebral cortex with
rabbit polyclonal anti-D-serine antibody was performed as described (Puyal et al., 2006) on
30 µm coronal brain sections of 2 month-old male rats. Images were acquired using a
confocal microscope (Leica TCS SP2) and colocalization was quantified using Image J
software as described (Martineau et al., 2008).
Statistical analysis
Uptake and acidification kinetics were analyzed using Prism4 software (GraphPad). Results
are reported as mean ± SEM from 3–6 independent experiments. Statistical significance was
defined at P<0.05 using the Student’s t-test.
Results
Glial Sb2-containing vesicles are similar to synaptic vesicles
Although D-serine was originally shown to be present in brain astrocytes (Schell et al., 1995;
Panatier et al., 2006; Williams et al., 2006), recent investigations have revealed that both D-
serine and its synthesizing enzyme, serine racemase, are also present in neurons
(Kartvelishvily et al., 2006; Miya et al., 2008). Therefore, to clarify the respective
contribution of astrocytes and neurons in D-serine disposition in the mature rat cerebral
cortex, we performed immunostainings for D-serine. Double immunostainings for D-serine
with the astroglial marker glutamine synthase in situ revealed that D-serine is mainly present
in the soma and processes of astroglia (Fig. 1A). The amino acid is uniformly distributed
among glial cells while double immunostainings with the pan-neuronal marker β3-tubulin
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indicated a moderate and uneven presence of D-serine in neuron soma and dendrites (Fig.
1A). Pre-embedding immunoperoxidase electron microscopy shows that D-serine is enriched
in glial processes apposed to excitatory synapses while absent from presynaptic terminals
and postsynaptic dendritic spines (Fig. 1B). Negative controls using a pre-absorbed anti-D-
serine polyclonal antibody did not show any peroxidase staining (Fig. 1C).
Ca2+-dependent exocytosis of gliotransmitters such as D-serine and L-glutamate requires their
compartmentalization into secretory organelles. As mentioned above, we have previously
shown that D-serine colocalizes with Sb2 (Martineau et al., 2008), raising the possibility that
D-serine is stored in such vesicles within astrocytes. To test whether such vesicles are indeed
capable of storing and/or transporting gliotransmitters, we immunoisolated Sb2-containing
organelles from a low speed supernatant (LSS) of cultured astrocytes using beads coated
with a monoclonal antibody specific for the cytoplasmic part of the SNARE protein Sb2
(Crippa et al., 2006; Martineau et al., 2008). Electron microscopy analysis revealed that the
immunoisolated organelles mainly consist of small, clear vesicles with a homogeneous size
distribution (40 ± 16 nm) (Fig. 2A,B). Thus, these isolated glial vesicles (GVs) are similar in
size and morphology to GVs and SVs observed in situ (Harris and Sultan, 1995; Bezzi et al.,
2004; Bergersen et al., 2012). Control beads coupled to non-immune IgG were devoid of
bound membranes, suggesting that nonspecific contamination by other membranes is
negligible. We next resolved the protein composition of immunoisolated GVs by
immunoblotting (Fig. 2C–E). No signal for Sb2 was observed in control bead fractions. The
immunoisolated organelles were devoid of the SV markers synaptophysin and
synaptotagmin 1, excluding any contamination by SVs (Fig. 2D). GVs contain vesicular
membrane proteins such as the SNARE protein cellubrevin, the V-ATPase, SV2 and the
vesicular glutamate transporter type 2 (vGlut2) (Fig. 2E). The immunoisolates were virtually
free of contamination by plasma membranes and other endomembranes (Fig. 2E) as evident
from the absence of signals for Na+-K+ATPase and SNAP23 (plasma membrane), protein
disulfide isomerase (PDI, endoplasmic reticulum), golgi matrix protein of 130 kDa (GM130,
Golgi apparatus), early endosome antigen 1 (EEA1) and transferrin receptor (TfR)
(endosomes), cathepsin D (lysosomes), and the 70 kDa peroxisomal membrane protein
(PMP70) (peroxisomes).
Purified GVs contain endogenous D-serine and L-glutamate
We next investigated whether purified GVs contain amino acids. Capillary electrophoresis
coupled to fluorescence detection revealed that GVs immunoisolated at 0 °C contained D-
serine and L-glutamate in amounts that were much higher than in vesicles immunoisolated at
21 °C or in control incubations (Fig. 3, corrected vesicular amount of D-serine: 0.052 ± 0.005
nmol/µg Sb2, of L-glutamate: 0.076 ± 0.039 nmol/µg Sb2). This agrees with previous reports
showing that amino acid neurotransmitters are only preserved inside synaptic vesicles when
isolated at 0 °C (Burger et al., 1991). Although γ-aminobutyric acid (GABA) has been
reported to be released by astroglia (Angulo et al., 2008), we could not detect significant
amount of GABA in GVs suggesting its release from a cytosolic pool. To further confirm
the identity of D-serine, we used conversion of D-serine by Rhodotorula gracilis D-amino acid
oxidase (RgDAAO) (Mothet et al., 2005) (Fig. 3A). The quantifications of serine and
glutamate were also confirmed using capillary electrophoresis separation under non-chiral
conditions followed by both fluorescence and mass spectrometry detections (Fig. 4).
To evaluate the physiological relevance of these results obtained on purified GVs, we
investigated the presence of both GVs and D-serine on pre-embedded cerebral cortex
preparations. Electron microscopy revealed the existence of clear round shaped organelles
(i.e., vesicle-like structures) in glia processes (Fig. 5A). Pre-embedding immunogold
stainings revealed that D-serine was associated with these vesicle-like structures in astrocytic
processes facing asymmetric synapses (Fig. 5A). No immunogold particles were observed in
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neuronal boutons (Fig. 5A) and in control conditions when brain slices were incubated with
a pre-absorbed anti-D-serine polyclonal antibody (Fig. 5B).
Cortical neurons also have been reported to release D-serine (Kartvelishvily et al., 2006;
Rosenberg et al., 2010). Therefore, SVs from the whole rat cerebral cortex were isolated
following the same procedure. As expected (Takamori et al., 2006), Sb2-containing SVs
express major SV proteins like synaptophysin, V-ATPase, and synaptotagmin 1 (Fig. 6A).
In agreement with previous work (Burger et al., 1991), SVs contain L-glutamate, glycine and
GABA (Fig. 3 and 6B). However, D-serine was not detected although it is present in the
cortex homogenate (Fig. 3 and 6B), supporting the notion that neurons do not exocytose D-
serine but release it from a cytosolic pool (Kartvelishvily et al., 2006; Rosenberg et al.,
2010). These results agreed with our observations that neuronal D-serine immunostaining
was confined to the soma of neurons but was excluded from their distal neurites or boutons
(Fig. 1 and 5).
Vesicular D-serine uptake is dependent on chloride concentration and is specific to
astroglia
The presence of D-serine in GVs suggests that GVs possess a specific transporter for this
gliotransmitter. Properties of vesicular transporters have been mainly studied in purified SV
fractions. All of them are driven by a proton electrochemical potential (ΔµH+) generated by
a V-ATPase (Edwards, 2007). We therefore examined whether GVs are capable of
transporting D-serine in the presence of a proton electrochemical gradient. As shown in Fig.
7A, this is indeed the case. Immunoisolated GVs showed ATP-dependent uptake of D-
[3H]serine that was blocked by the V-ATPase inhibitor bafilomycin and sensitive to the
uncoupler FCCP. Next, we tested whether the vesicles also transport glutamate as suggested
by the presence of vGlut2 (Fig. 2) (Bezzi et al., 2004; Crippa et al., 2006). Again, ATP-
dependent transport of L-[3H]glutamate was observed (Fig. 7A).
The proton electrochemical potential ΔµH+ has two components, the membrane electric
potential (ΔΨ) and the pH gradient (ΔpH). In SVs, the relative contribution of the two
components is determined by the presence of chloride which provides charge balance to H+
(Edwards, 2007). To characterize the dependence of D-serine uptake by GVs on the
components of ΔµH+, we monitored vesicular acidification using the pH-sensitive dye,
acridine orange (AO). Surprisingly, no ATP-dependent acidification was observed when Cl−
was added up to a concentration of 100 mM (Fig. 7B), in contrast to SVs that show strong
acidification in the presence of chloride (Hell et al., 1990; Schenck et al., 2009). Apparently,
GVs are impermeant to Cl−. In contrast, addition of D-serine induced a dose-dependent
acidification of GVs with a KM of 6.9 mM for the initial rate of acidification (Fig. 7C,D). D-
serine-dependent acidification as well as D-[3H]serine uptake were, however, completely
dependent on the presence of chloride, with a maximum at 4 mM chloride that then declined
slightly at higher chloride concentrations (Fig. 7E,F). These results indicate that, at least
under these conditions, chloride provides charge balance for the protons during the uptake of
D-serine (which contains no net charge at neutral pH), suggesting that D-serine uptake is
coupled to chloride transport. Replacement of K+ by Na+ and of SO42− by gluconate shows
no influence of these ions on the ΔpH induced by D-serine (data not shown). The effect of
chloride on the vesicular D-serine transport prompted us to assess the relative contribution of
both components of the proton electrochemical potential ΔµH+ to the vesicular uptake of D-
serine. The K+ ionophore, valinomycin, and the K+/H+ exchanger, nigericin, selectively
abolish ΔΨ or ΔpH of ΔµH+, respectively. FCCP-sensitive D-[3H]serine transport in GVs was
reduced evenly to ～35% by valinomycin or nigericin, indicating that both the electrical
(ΔΨ) and chemical (ΔpH) components of ΔµH+ are required for full activity of the vesicular
D-serine transporter (Fig. 7G). The combination of valinomycin and nigericin dissipated both
ΔΨ and ΔpH resulting in an almost complete inhibition of the D-[3H]serine uptake (Fig. 7G).
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These results together with the role of chloride on D-serine transport strengthen our model in
which D-serine and chloride uptake are coupled in GVs and, additionally, suggest an
exchange of D-serine/chloride for protons. Contrary to L-glutamate, neither acidification nor
transport are observed when D-serine is added to SVs (Fig. 8A,B), which in combination
with the absence of D-serine inside SVs (Fig. 3, 5 and 6) demonstrates that the vesicular
transport for D-serine is specific to GVs.
L-glutamate uptake in GVs and SVs share the same properties
The surprising properties of GVs with respect to acidification prompted us to investigate the
properties of glutamate-induced acidification. In SVs, glutamate transport has been shown to
be associated with acidification (Fig. 8A), suggesting that glutamate serves as counterion for
proton transport (Maycox et al., 1988; Schenck et al., 2009). However, glutamate uptake is
also dependent on the presence of chloride. Since chloride on its own induces strong
acidification of SVs, it has been difficult to resolve to which extent the effects of chloride
are direct (e.g., as activator of vGlut activity) or indirect by shifting the balance between ΔΨ
and ΔpH, and the role of chloride in activation and the transport cycle of vGluts is
controversial (Schenck et al., 2009; Juge et al., 2010). Similar to SVs (Fig. 8A), glutamate
induced acidification of GVs (Fig. 7D). The apparent KM was 2.2 mM, similar to that
reported for SVs (Naito and Ueda, 1985; Maycox et al., 1988), with the maximal rate being
comparable to that induced by D-serine (Fig. 7D). Similar to D-serine, chloride has a biphasic
effect on L-glutamate transport, with activation at low concentrations (4 mM) and inhibition
at high concentrations (>50 mM) (Fig. 7E), resembling previous reports from SVs (Hell et
al., 1990; Schenck et al., 2009). In contrast to D-serine-induced acidification, significant
uptake was already measured in the absence of chloride. However, the inhibition at high
chloride concentrations is weaker in GVs than that reported for SVs (Hell et al., 1990;
Schenck et al., 2009). This discrepancy may be due to the lack of chloride permeability of
GVs that thus cannot dissipate ΔΨ, the component of the electrochemical potential fuelling
glutamate uptake (Hell et al., 1990; Schenck et al., 2009).
D-Serine and L-glutamate vesicular loading exert mutual stimulation
D-Serine and L-glutamate are both stored and transported inside GVs. vGluts have been
shown to enhance vesicular loading of GABA and monoamines in nonglutamatergic neurons
through a process called vesicular synergy (for review, see El Mestikawy et al., 2011). Such
vesicular synergy has not yet been described for gliotransmitters. Therefore, we investigated
whether both amino acids could be present in the same GVs and to what extent L-glutamate
is able to modulate the accumulation of D-serine inside GVs, and vice versa. To this end, the
acidification induced by one amino acid was measured in the presence or absence of the
other. Under standard conditions, the D-serine-induced acidification was unaffected by the
presence of L-glutamate. On the contrary, 5 mM D-serine markedly accelerates to ～280% the
initial rate of acidification induced by L-glutamate (Fig. 9A,B). To determine if the vesicular
acidification rate reflects the amino acid accumulation, we measured the transport of L-
[3H]glutamate in GVs for 10 min in presence of 10 mM D-serine, and vice versa. Consistent
with the acidification assay, FCCP-sensitive L-[3H]glutamate uptake by GVs was
reproducibly increased by ～350% in the presence of D-serine (Fig. 9B). Conversely, L-
glutamate had a slightly smaller stimulatory effect (～225%) on D-[3H]serine uptake, which
was not revealed by the indirect measure of the initial rate of loading. The interplay between
D-serine and L-glutamate uptakes may reflect their common dependency on chloride.
However, the influence on the loading rate and amplitude exerted by one amino acid on the
other is not absolutely symmetrical. Since L-glutamate uptake relies mostly on ΔΨ while D-
serine uptake depends more equally on both ΔΨ and ΔpH, this discrepancy may be due to
their bioenergetic properties.
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SVs are devoid of any transport activity for D-serine (Fig. 8). Therefore, in order to finally
address whether the stimulation of vesicular L-glutamate transport by D-serine is due to the
presence or to the transport of the amino acid, we analysed the effect of 10 mM D-serine on
L-glutamate loading inside SVs. In contrast to GVs, D-serine had no effect on L-glutamate
uptake in SVs, excluding a direct action of D-serine on vGlut but rather suggesting a synergic
effect of D-serine uptake on vGlut activity (Fig. 9B).
Uptake of newly synthesized D-serine is coupled to the activity of GV-associated serine
racemase
To characterize the substrate stereoselectivity of D-serine transport, we investigated the effect
of L-serine on GV acidification. Addition of L-serine induced acidification of GVs with an
initial rate of acidification comparable to that of D-serine (Fig. 10A,C), suggesting that the
vesicular transporter does not discriminate between the enantiomers. However, L-serine is
not retrieved in isolated GVs (Fig. 3). In addition, L-serine did not further induce
acidification when GVs were preloaded with D-serine, and vice versa (data not shown). We
therefore tested whether L-serine is first converted to D-serine by serine racemase (SR).
While SR is reported to be principally cytosolic (Balan et al., 2009), confocal microscopy
analysis revealed a particulate staining pattern, displaying significant colocalisation between
SR and Sb2 in cultured astrocytes from rat brain cortex (20.6 ± 8.9% Sb2 versus SR, 25.2 ±
11.5% SR versus Sb2) (Fig. 10B), similar to the colocalization between D-serine and Sb2
(Martineau et al., 2008). Immunoblotting then revealed that SR is present in purified GVs
(Fig. 10B) but absent from SVs (Fig. 8C). Thus, SR appears to be anchored to Sb2-
containing GVs, suggesting that L-serine is converted to D-serine that is then transported into
GVs. Such a vesicular localization may guarantee local high concentrations of the substrate,
which may be advantageous for efficient transport of this gliotransmitter. Indeed, incubation
of GVs with a potent competitive inhibitor of SR, L-erythro-3-hydroxyaspartate (HOAsp)
(Strisovsky et al., 2005) strongly reduced L-serine-induced acidification without affecting the
acidification induced by D-serine (Fig. 10C,D). Since the acidification kinetics measured for
L-serine and D-serine without HOAsp are identical, neither newly synthesized nor pre-
existing D-serine is taken up preferentially. Finally, similar to vGluts (Naito and Ueda,
1985), the transporter for D-serine is stereoselective.
Discussion
In this study we have isolated and characterized a population of small, clear vesicles from
astrocytes with both morphological and biochemical features reminiscent of neuronal SV.
We show that these vesicles contain the endogenous gliotransmitters D-serine and L-
glutamate and possess specific transport activities for these transmitters. We further
characterized the properties of D-serine uptake and found that this transport activity is
specific for astroglia, associated with vesicle acidification, dependent on chloride and is
stereoselective. While D-serine synthesizing enzyme SR is present at the membrane of GVs,
we observed a functional coupling between SR activity and D-serine vesicular transport.
Finally, we provided evidence for an unexpected vesicular synergy between D-serine and L-
glutamate uptake in astrocytes. Together, our findings lend strong support to the view that
both L-glutamate and D-serine are released from astroglia by exocytosis from storage
organelles with properties reminiscent of neuronal SVs.
The small vesicles immunoisolated from rat cortical astrocytes in culture share
morphological and molecular properties with vesicles previously characterized from
astrocytes in situ using immunocytochemistry and immunoelectron microscopy, notably
their homogenous size (～40 nm in diameter), round shape, clear appearance and presence of
vGlut and SNARE proteins (Bezzi et al., 2004; Bergersen et al., 2012). It suggests that the
vesicles isolated and characterized by us do indeed correspond to the GVs described earlier.
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The morphological properties of GVs are also similar to those of synaptic vesicles (Harris
and Sultan, 1995; Bergersen et al., 2012). Apparently, the two organelles also share some of
the major proteins including Sb2, the V-ATPase, vGlut2 and SV2. However, other major SV
proteins (such as synaptophysin and synapsins) are known to be absent from glial cells, and
further work, involving quantitative comparisons of major proteins, is required to assess
similarities and differences in the protein composition. Most importantly, the subcellular
distribution clearly distinguishes GVs from SVs. According to electron microscopy
analyses, GVs are far less abundant in astroglial processes than SVs in synaptic boutons.
The dominance of SVs in the neuropil may explain why the presence of vesicular proteins in
astroglia has been difficult to demonstrate in situ (Cahoy et al., 2008). The lower abundance
of these organelles also required a modification of the immunoisolation protocol for GVs in
comparison to SVs, involving upscaling of starting material, higher concentration of beads
and coupled antibodies, and longer incubation times (see Materials and Methods).
In the present study, we show conclusively that two gliotransmitters, namely L-glutamate and
D-serine, are stored inside GVs. However, these amino acids are retained by GVs only when
isolated under appropriate conditions. Leakage of L-glutamate and D-serine can be prevented
or at least minimized when vesicle isolation is carried out at 0 °C, in agreement with earlier
reports on SVs (Burger et al., 1991). We cannot exclude that even under these conditions
some efflux of amino acids occurred. The actual vesicular content may thus be higher than
that found in our experiments. Since we do not know the number of Sb2 copies per GV, it is
not possible to provide an accurate estimate of the intravesicular concentration of these
amino acids. Presently, we cannot exclude the presence of other small organic molecules in
GVs as indicated by unidentified peaks in the electropherograms.
This is the first demonstration of a specific vesicular transporter for D-serine with features
reminiscent of, but not identical to, the well-established vesicular transporters for excitatory
and inhibitory amino acids. D-serine is transported into GVs with an affinity similar to the
affinity of the vesicular inhibitory amino acid transporter (VIAAT) for GABA (Christensen
et al., 1991). Our work has revealed key features of D-serine vesicular transport: it is specific
for astroglia, dependent on both components of ΔµH+ produced by a V-ATPase, associated
with proton transport and requires chloride for activation. Since D-serine has no net charge at
neutral pH and chloride is required for vesicular acidification induced by D-serine, we
propose that chloride provides charge balance while being co-transported with D-serine in a
coupled or uncoupled manner. A coupled transmitter/chloride co-transport mechanism has
already been proposed for VIAAT (Juge et al., 2009). Alternatively, the vesicular D-serine
transporter (VSERT) may harbour an uncoupled anion conductance activated by substrates,
as reported for plasma membrane glutamate transporters (Fairman et al., 1995; Ryan and
Mindell, 2007). Together, these data are compatible with a model in which the putative D-
serine transporter operates as a D-serine/H+ antiporter (Fig. 11). In addition, our study reveals
that a spatial association of SR activity and D-serine vesicular transport results in a functional
coupling between synthesis and uptake which has previously been described in SVs for
GABA and dopamine (Chen et al., 2003; Jin et al., 2003; Cartier et al., 2010). The presence
of SR at the membrane of GVs allows a local synthesis of D-serine and thus favors the
efficient transport of the gliotransmitter. However, in contrast to GABA and dopamine
(Chen et al., 2003; Jin et al., 2003), pre-existing D-serine is taken up into GVs without any
preference over a newly synthesized one. Therefore, it is unlikely that the activity of SR
directly influence the transport activity for D-serine. Brain SR does not possess a
transmembrane region (Balan et al., 2009). This is also the case for the tyrosine hydroxylase
and glutamate decarboxylase, the synthesizing enzymes for GABA and dopamine.
Intriguingly, these enzymes are associated with the respective storage vesicles, apparently
by means of a specific interaction with the respective transporters (Jin et al., 2003; Cartier et
al., 2010). It is conceivable that vesicle binding SR is also mediated by an interaction with
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the vesicular D-serine transporter, but for this issue to be addressed the transporter needs to
be identified. Previously, binding of SR to the plasma membrane of astrocytes and neurons
has been described (Balan et al., 2009; Mustafa et al., 2009). This binding occurs through
interaction with phosphatidylinositol (4,5)-biphosphate (PIP2) in astrocytes (Mustafa et al.,
2009) or through posttranslational modifications in neurons (Balan et al., 2009), and leads to
inactivation of the enzyme. In contrast, our data show that vesicle-bound SR is active,
suggesting that the binding mechanism is different. Inactivation of SR at the plasma
membrane may be a means to stop conversion of L-serine at the “wrong” place, i.e., after
incorporation of the GV membrane into the plasma membrane following exocytosis.
The presence of vesicular glutamate transporters and vesicular transport activity for L-
glutamate has already been observed in astrocytes (Bezzi et al, 2004; Crippa et al., 2006;
Bergersen et al., 2012). However, L-glutamate uptake inside GVs has not been fully
characterized. In our study, we confirmed these previous reports and further analysed the
uptake properties of this amino acid inside GVs. We demonstrated that L-glutamate is
transported by GVs with an apparent affinity and a biphasic chloride dependency similar to
that reported for SVs (Naito and Ueda, 1985; Maycox et al., 1988). However, in contrast to
SVs we did not observe chloride-dependent acidification, which is difficult to reconcile with
vGlut2 functioning as a chloride channel as recently suggested for vGlut1 (Schenck et al.,
2009). The lack of a transport-independent chloride conductance compensating for proton
transport is a major distinguishing feature of GV versus SV transport which requires further
investigation.
The storage and transport of both D-serine and L-glutamate in GVs raises the question of their
possible co-storage and thus co-release. Our vesicular content analyses (Fig. 3,4) do not
allow us to distinguish between one population containing both gliotransmitters or two
distinct populations dedicated to one gliotransmitter. Recently, immunogold colabelling of D-
serine and L-glutamate in the adult hippocampus revealed that both amino acids are
presumably stored in distinct vesicular pools (Bergersen et al., 2012). However the limited
sensitivity of the immunogold technique does not allow unequivocal conclusion. Here, we
report that D-serine transport stimulates L-glutamate uptake in GVs, indicating a functional
cross-talk between the two transporters that can only be explained by both transporters
residing on the same vesicle. The mechanism underlying this vesicular synergy between
both amino acid uptakes requires further investigation. Whatever the mechanism, glial
cytoplasmic D-serine when transported in GVs would be able to amplify L-glutamate-
mediated gliotransmission. Interestingly, co-release of both gliotransmitters from the same
vesicle would be a perfect combination for activating NMDA receptors. To our best
knowledge, we provide the first experimental evidence for a cotransmitter action on
vesicular glutamate uptake and extend the notions of both co-release and vesicular synergy
beyond neurons. However, the existence of a population of GVs storing and releasing both
D-serine and glutamate does not exclude the possibility of GVs loaded with one but not the
other gliotransmitter.
In conclusion, our work supports the concept that astrocytes possess specific vesicles
capable of sequestering and storing D-serine and L-glutamate as gliotransmitters, which
undergo calcium-dependent exocytosis and modulate synaptic transmission. Additionally,
the vesicular synergy unravelled in glial cells would represent a safe-cost metabolic process
by reducing the energy demand of regulated exocytosis.
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Figure 1.
D-serine distribution in the rat cerebral cortex. A, Confocal microscopy analysis of
immunostainings of D-serine versus astroglial (glutamine synthase, GS) or neuronal (β3-
tubulin) markers in the rat cerebral cortex. Arrowheads: D-serine-containing neurons, arrows:
D-serine positive astrocytes. Control: staining with a nuclear marker, DAPI (blue) and an
anti-D-serine antibody previously pre-absorbed with 500 µM of liquid-phase D-serine
glutaraldehyde conjugate. Scale bars: 30 µm. B, Representative electron micrographs of D-
serine pre-embedding immunohistochemistry using the peroxidase method showing that D-
serine immunoreactivity is mainly distributed in astrocytic processes (arrows) at the level of
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asymmetric synapses in the rat cerebral cortex. C, Representative low magnification (upper
panel) and high magnification (lower panel) electron micrographs showing that no
peroxidase staining is detected with a pre-absorbed anti-D-serine antibody. Ast, astrocyte; D,
dendrite; S, dendritic spine; B, axonal bouton. Scale bars: 500nm.
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Figure 2.
Characterization of glial vesicles (GV), immunoisolated from cultured astrocytes using
beads coated with anti-synaptobrevin 2 monoclonal antibodies. A, Electron micrographs of
the bead fraction, showing vesicles bound to the surface of the beads. Ctl: Immunobeads
coated with mouse IgG that were processed in parallel, no bound vesicles are detectable.
Arrows: bead-bound vesicles. Scale bars: 100 nm. B, Size distribution of the
immunoisolated vesicles. A total of 300 vesicles was measured, with the numbers falling
into the respective categories indicated in the histogram. The black curve shows a Gaussian
fit of the size distribution. C, Astroglial low-speed supernatant (LSS) and bead-bound
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material (IP) were immunoblotted for Sb2. Equal proportion of samples was loaded showing
that a major fraction of Sb2-positive organelles was recovered in the bead fraction. Light
and heavy chains correspond to light and heavy chains of mouse control (lane 2) and
monoclonal anti-Sb2 antibodies (lane 3). D, E, Immunoblots of the fractions shown in panel
C for various marker proteins specific for SVs (D) and subcellular compartments (E). Sph:
synaptophysin, Stg 1: synaptotagmin 1.
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Figure 3.
Amino acid content of immunoisolated glial (GV) and synaptic (SV) vesicles. A, Astroglial
low-speed supernatant (LSS), Sb2-containing vesicles immunoisolated at 21 °C and at 0 °C
with or without RgDAAO treatment were analyzed by capillary electrophoresis (CE).
Electropherograms are adjusted to the same scale to facilitate the comparison between
traces. Arrows point to the position of L-serine (LS), D-serine (DS), GABA + unknown
substance (γ*), glycine (G) and L-glutamate (E). B, Quantification of amino acid content of
GVs and SVs isolated at 0 °C. All values were corrected for nonspecific adsorption as
determined by isolating vesicles at 21 °C. The figure shows mean values ± SEM of 4
independent experiments, normalized to synaptobrevin 2 as a vesicle marker.
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Figure 4.
Quantitation of vesicle amino acid content using CE-LIF and CE-MS. To validate
quantitation via CE-LIF chiral separations as shown in Fig. 3A, two additional
measurements using non-chiral separation conditions were performed using CE with laser
induced fluorescence (CE-LIF) detection and CE with mass spectrometric (CE-MS)
detection to validate the quantitative measures and peak assignments. A, Astroglial Sb2-
containing vesicles immunoisolated at 21 °C and at 0 °C were analyzed using a non-chiral
CE-LIF separation. Arrows point to the serine (S), GABA (γ), glycine (G) and glutamate (E)
peaks. B, The same samples were analyzed by CE-MS. Electropherograms were adjusted to
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the same scale to facilitate comparison between approaches. C, A table shows representative
quantification results of serine using these three different methods.
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Figure 5.
Pre-embedding immunogold staining for D-serine at glia-neuron interfaces in rat cerebral
cortex. A, Low magnification shows that immunogold-positive particles (arrows) are
detected in astrocytic processes surrounding asymmetric synapses. High magnifications
reveal that D-serine is associated with vesicle-like structures located in astrocytic processes
facing the asymmetric synapses. Please note that the insets are rotated compared to the low
magnification image. B, Representative low magnification (upper panel) and high
magnification (lower panel) electron micrographs showing that no immunogold-positive
particle is detected with a pre-absorbed anti-D-serine antibody. Ast, astrocyte; D, dendrite; S,
dendritic spine; B, axonal bouton. Scale bars: 500 nm.
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Figure 6.
Characterization of immunoisolated synaptic vesicles. A, Cortex homogenate (Input), and
bead-bound material (IP) were immunoblotted for Sb2, V-ATPase (subunit a1),
synaptophysin, synaptotagmin 1, and for the endosomal marker EEA1. Equal proportion of
samples was loaded to allow direct comparison. Light and heavy chains correspond to light
and heavy chains of antibodies. B, Cortex homogenate, Sb2-containing synaptic vesicles
immunoisolated at 21 °C and at 0 °C were analyzed by CE-LIF. Electropherograms are
adjusted to the same scale to facilitate the comparison between traces. Arrowheads point to
the position of L-serine (LS), D-serine (DS), GABA (γ), glycine (G) and L-glutamate (E).
Quantification of amino acid content in SVs is presented in Fig. 3B for comparison with
GVs.
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Figure 7.
Features of vesicular D-serine uptake into astrocytic immunopurified vesicles. A, ATP-
dependent uptake of D-[3H]serine and L-[3H]glutamate. The values represent FCCP-sensitive
uptake. FCCP (40 µM) was added together with MgATP (4 mM). Control experiments are
performed by replacing MgATP by ATPγS (4 mM), by decreasing temperature to 0 °C, or
by inhibiting V-ATPase with bafilomycin A1 (1 µM). B D-Serine (7.5 mM) mediated
acidification of GVs is dependent on chloride (the figure shows representative traces from
3–6 independent measurements). To maintain ionic strength and osmolarity, chloride was
exchanged for gluconate (potassium salts). Arrows correspond to addition of the tested
compound (ATP 10 mM and (NH4)2SO4 50 mM, final concentrations in this and the
following figures). At the end of the reaction, (NH4)2SO4 was added to dissipate ΔpH. C,
Overlay of photometric traces showing acidification of GVs induced by various D-serine
concentrations in presence of 4 mM chloride (representative of 3–5 independent
experiments). No change in fluorescence under any condition was observed when control
beads (mouse IgG) were used. Scale bars represent 2 a.u. per 1 min. D, Dependence of the
initial rate of acidification on D-serine and L-glutamate concentration. E, F, Initial rate of
acidification induced by D-serine (7.5 mM) or L-glutamate (5 mM) and D-[3H]serine uptake
were measured in the presence of different chloride concentrations. G, Influence of both
components of the proton electrochemical potential ΔµH+ on FCCP-sensitive ATP-
dependent D-[3H]serine uptake. Additions: 5 µM nigericin, 20µM valinomycin. Error bars
represent mean ± SEM; n = 3–6 independent experiments.
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Figure 8.
Synaptic vesicles transport L-glutamate, but not D-serine. A, Photometric trace showing the
absence of D-serine-induced acidification of synaptic vesicles whereas L-glutamate can
acidify these organelles (10 mM each, n = 3). Scale bar: 2 a.u. per 1 min. B, ATP-dependent
uptake of D-[3H]serine and L-[3H]glutamate by isolated SVs. The values represent FCCP-
sensitive uptake. N.D. not detectable. Values represent mean ± SEM of 2 independent
experiments performed in triplicate. C, Western blot analysis of cortex homogenate (Input)
and control or Sb2 immunoisolates (IP) for vesicular glutamate transporters vGlut1 and
vGlut2 and for serine racemase (SR).
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Figure 9.
Vesicular synergy between D-serine and L-glutamate transport activities in GVs. A, Partial
photometric traces showing the acidification induced by 5 mM D-serine (upper part) and 5
mM L-glutamate (lower part) in absence (black) or presence (grey) of 5 mM L-glutamate and
5 mM D-serine, respectively. The experiments were performed as in Fig. 7, i.e. initiated with
10 mM ATP and ended with 50 mM (NH4)2SO4. Scale bar represents 2 a.u. per 1 min. B,
Histogram showing the reciprocal effect of each amino acid (D-serine or L-glutamate) on the
acidification rate and uptake of the other one. Amino acid-induced acidification was
measured as in panel A. FCCP-sensitive ATP-dependent uptakes of L-[3H]glutamate or D-
[3H]serine were measured in presence of 10 mM D-serine or L-glutamate, respectively. Error
bars represent mean ± SEM; n = 3 for acidification, 4 in duplicate for radioactive assay.
*P<0.05, **P<0.01, Student’s t test.
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Figure 10.
D-serine uptake by immunoisolated GVs is coupled to endogenous serine racemase activity.
A, Photometric trace showing acidification induced by 10 mM L-serine (representative trace
from 4 independent experiments). Scale bar: 2 a.u. per 1 min. B, Colocalization of serine
racemase (SR, green) with synaptobrevin 2 (Sb2, red) in cultured astrocytes. Scale bars: 10
µm for the upper image (low magnification) and 5 µm for the zooms. The presence of serine
racemase on GVs is confirmed by immunoblotting of immunoisolated GV fractions. C, D,
Inhibition of serine racemase by L-erythro-3-hydroxyaspartate (HOAsp, 400 µM, 10 min)
abolishes L-serine-induced acidification without affecting D-serine-induced acidification (10
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mM each, representative traces from 4–5 independent experiments). Scale bars: 2 a.u. per 1
min. ns: not significant, *P<0.05, **P<0.01, Student’s t test.
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Figure 11.
Vesicular D-serine transporter (VSERT) operates as a putative D-serine/H+ antiporter with a
chloride leak or a coupled chloride cotransport. While D-serine is a neutral amino acid,
chloride acts as a counter-ion for V-ATPase and increases the pH gradient while reducing
the membrane potential. Alternatively, chloride could modulate D-serine transport by
regulatory binding to the transporter. Serine racemase is anchored to the membrane of GVs
where it converts L-serine into D-serine allowing a local and efficient concentration of the
gliotransmitter to be transported. However, pre-existing D-serine is also taken up in GVs
without any preference over a newly synthesized one.
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